Call Scheduled for August 14, 2025, at 8:30 AM Eastern TimeNEW YORK, Aug. 8, 2025 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, announced today that it will hold a conference call and webcast to update shareholders on financial results for the second quarter of 2025, at 8.30 a.m. Eastern Time on August 14, 2025.BrainStorm's President and Chief Executive Officer, Chaim Lebovits, will provide the update. Har ...